Skip to main content
SpringerLink
Log in

Specific assays of hemostasis proteins: Factor VII

  • From Meetings
  • 2nd International Symposium On Standardization And Quality Control Of Coagulation Tests: Implications For The Clinical Laboratory
  • Published:
Research in Clinic and Laboratory

Summary

Factor VII (FVII) activity should be measured in order to evaluate the risk for coronary artery disease. The measurement of FVII by means of a standardized clotting method seems to be influenced by the thromboplastins used, while the FVII-deficient plasmas do not affect the results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dalaker K., Hjermann I., Prydz H.: A novel form of factor VII in plasma from men at risk for cardiovascular disease — Brit. J. Haematol.61, 315, 1985.

    Article  CAS  Google Scholar 

  2. Hoffman C., Shah A., Sodums M., Hultin M. B.: Factor VII activity state in coronary artery disease — J. Lab. clin. Med.111, 475, 1988.

    PubMed  CAS  Google Scholar 

  3. Kannel W. B., Wolf P. A., Castelli W. P., D’Agostino R. B.: Fibrinogen and risk of cardiovascular disease. The Framingham Study — J. Amer. med. Ass.258, 1183, 1987.

    Article  CAS  Google Scholar 

  4. Meade T. W., Mellows S., Brozovic M., Miller G. J., Chakrabarti R. R., North W. R. S., Haines A. P., Stirling Y., Imeson J. D., Thompson S. G.: Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study — Lancetii, 533, 1986.

    Article  Google Scholar 

  5. Meade T. W., North W. R. S., Chakrabarti R. R., Stirling Y., Haines A. P., Thompson S. G.: Haemostatic function and cardiovascular death: early results of a prospective study — Lanceti, 1050, 1980.

    Article  Google Scholar 

  6. Miller G. J., Martin J. C., Webster J., Wilkes H., Miller N. E., Wilkinson W. H., Meade T. W.: Association between dietary fat intake and plasma factor VII coagulant activity — a predictor of cardiovascular mortality — Atherosclerosis60, 269, 1986.

    Article  PubMed  CAS  Google Scholar 

  7. Miller G. J., Walter S. J., Stirling Y., Thompson S. G., Esnouf M. P., Meade T. W.: Assay of factor VII activity by two techniques: evidence for increased conversion of VII to α-VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease — Brit. J. Haematol.59, 249, 1985.

    Article  CAS  Google Scholar 

  8. Poggio M., Tripodi A., Mariani G., Mannucci P. M.: Evaluation of a standard clotting method for factor VII measurement — Thrombos. Haemostas. (Submitted for publication).

  9. Scarabin P. Y., Bara I., Samama M., Orssaud G.: Further evidence that activated factor VII is related to plasma lipid — Brit. J. Haematol.61, 177, 1985.

    Article  Google Scholar 

  10. Wilhelmsen L., Svärdsudd K., Korsan-Bengtssen K., Larsson B., Welin L., Tibblin G.: Fibrinogen as a risk factor for stroke and myocardial infarction — New Engl. J. Med.311, 501, 1984.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Servizio di Immunoematologia e Centro Trasfusionale, Ospedale L. Sacco, Via G. B. Grassi 74, 20157, Milano, Italia

    Marina Poggio

Authors
  1. Marina Poggio
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

For the CISMEL (Comitato Italiano per la Standardizzazione dei Metodi in Ematologia e Laboratorio) Hemostasis Subcommittee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poggio, M. Specific assays of hemostasis proteins: Factor VII. Res. Clin. Lab. 20, 139–141 (1990). https://doi.org/10.1007/BF02877560

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02877560

Key-words

Search

Navigation